THE Society of Hospital Pharmacists of Australia (SHPA) is now calling on the Federal Govt to implement the recommendations of the report into assessment and support services for people with Attention-Deficient/Hyperactivity Disorder (ADHD).
The final report, which outlines 15 recommendations, included three that were supported by written submission and evidence provided by SHPA representatives Natalie Tasker (pictured) and Jerry Yik.
As the only pharmacy organisation to contribute to the Senate Community Affairs References Committee inquiry, SHPA stated it is keen to see the implementation of recommendations that include broadening PBS criteria for ADHD medicines access.
Further, ensuring that Australian patients receive timely assessment and support services through expanding the scope of practice for healthcare professionals.
And, expediting the development of uniform prescribing rules to ensure consistency between states and territories.
Tasker, a member of the SHPA Paediatrics and Neonatology Leadership Committee, said she was especially proud to contribute to the proceedings and see hospital pharmacy recommendations accepted in the final report.
Tasker explained that it is often challenging for patients and families to navigate the use of stimulant therapy which is made "unnecessarily complex by different jurisdictional requirements," depending on the state or territory where the patient is receiving treatment and where their prescription is dispensed.
"As pharmacists, we have long advocated for national consistency in prescribing rules so we can spend more time doing clinically meaningful work and less time dealing with paperwork," she said. JG
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Nov 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Nov 23
